Browse Category

Earnings Reports News 18 December 2025 - 19 December 2025

Costco Stock (COST) After Hours Today (Dec. 18, 2025): Price Action, Fresh Forecasts, and What to Watch Before Friday’s Market Open

Costco Stock (COST) After Hours Today (Dec. 18, 2025): Price Action, Fresh Forecasts, and What to Watch Before Friday’s Market Open

Costco Wholesale Corporation (NASDAQ: COST) finished Thursday’s regular session under modest pressure—and then barely budged after the closing bell, a sign that traders are still digesting the same debate that has dominated Costco’s tape for much of 2025: strong operating performance vs. a still-premium valuation. By the 4:00 p.m. ET close on December 18, 2025, COST ended at $857.59, down…
Eaton (ETN) Stock After Hours on Dec. 18, 2025: Wells Fargo Cuts Target, Inflation Cools, and What to Watch Before Friday’s Open

Eaton (ETN) Stock After Hours on Dec. 18, 2025: Wells Fargo Cuts Target, Inflation Cools, and What to Watch Before Friday’s Open

Eaton Corporation plc (NYSE: ETN) ended Thursday’s regular session essentially flat—and stayed steady after the closing bell—as investors weighed a fresh analyst price-target cut against a broader market rebound tied to softer inflation data. By late after-hours trading on Thursday, Dec. 18, 2025, ETN was hovering around $315.95, up about 0.04% from the prior close. Eaton stock after the bell:…
Eli Lilly Stock (LLY) After Hours Today (Dec. 18, 2025): Orforglipron Headlines, Analyst Forecasts, and What to Watch Before Friday’s Open

Eli Lilly Stock (LLY) After Hours Today (Dec. 18, 2025): Orforglipron Headlines, Analyst Forecasts, and What to Watch Before Friday’s Open

Eli Lilly and Company (NYSE: LLY) finished Thursday’s session higher and held those gains in after-hours trading, as investors digested fresh late-stage data for its oral obesity candidate orforglipron—and weighed a second, potentially market-moving theme: pricing pressure and affordability initiatives. As of early evening after the closing bell, LLY was little changed in after-hours trading at $1,057.26 (+0.04%), after closing…
AMD Stock After Hours Today (Dec. 18, 2025): What’s Driving Advanced Micro Devices (AMD) and What to Watch Before Friday’s Open

AMD Stock After Hours Today (Dec. 18, 2025): What’s Driving Advanced Micro Devices (AMD) and What to Watch Before Friday’s Open

Advanced Micro Devices (NASDAQ: AMD) finished Thursday’s regular session higher, then eased slightly in extended trading—an end-of-day pattern that reflects the push-and-pull currently dominating chip stocks: strong AI-linked demand signals on one hand, and persistent “AI financing” nerves on the other. AMD stock closed at $201.06 at 4:00 p.m. ET, up about 1.5% on the day. In after-hours trading, AMD…
FedEx Q2 Earnings Beat: FDX Raises 2026 Profit Forecast as Network 2.0 Overhaul Gains Traction

FedEx Q2 Earnings Beat: FDX Raises 2026 Profit Forecast as Network 2.0 Overhaul Gains Traction

FedEx delivered a stronger-than-expected fiscal second quarter and raised its full-year outlook on Thursday, December 18, 2025, as the shipping giant said peak-season pricing, higher package yields, and structural cost reductions helped offset a difficult macro and trade backdrop. The update lands as FedEx pushes ahead with a sweeping, multi-year overhaul of its network and prepares to spin off its…
Nike (NKE) Q2 2026 Earnings Surprise: Revenue Beats Estimates, But China Weakness and Tariff Costs Pressure Margins

Nike (NKE) Q2 2026 Earnings Surprise: Revenue Beats Estimates, But China Weakness and Tariff Costs Pressure Margins

BEAVERTON, Ore. (Dec. 18, 2025) — Nike’s latest earnings report delivered a familiar split-screen for investors: a clear top-line surprise powered by North America, paired with profitability pressure from tariffs, promotions, and a still-soft China business. For its fiscal 2026 second quarter (ended Nov. 30, 2025), Nike reported revenue of $12.43 billion, up 1% year over year (flat on a…
Micron Stock (MU) After Hours Today: Shares Hold a 10% Jump After Blowout Guidance — What to Watch Before Friday’s Open (Dec. 19, 2025)

Micron Stock (MU) After Hours Today: Shares Hold a 10% Jump After Blowout Guidance — What to Watch Before Friday’s Open (Dec. 19, 2025)

Micron Technology, Inc. (NASDAQ: MU) is ending Thursday, December 18, 2025, in the spotlight — and still moving after the closing bell — after the market spent the day repricing what many analysts are calling a new phase in the memory-chip cycle driven by AI infrastructure demand. After the bell, Micron shares hovered around $248.55, up about 10.24% from the…
Amazon Stock After Hours Today (Dec. 18, 2025): AMZN Holds Gains Near $227 as CPI Cools — What to Know Before Friday’s Open

Amazon Stock After Hours Today (Dec. 18, 2025): AMZN Holds Gains Near $227 as CPI Cools — What to Know Before Friday’s Open

Amazon.com, Inc. (NASDAQ: AMZN) finished Thursday’s session on an upbeat note and is sitting relatively steady after the closing bell, as investors weigh a softer-than-expected inflation print, a tech-led market rebound, and a fresh wave of Amazon-focused headlines—from AI leadership moves to Wall Street’s 2026 outlooks. Amazon stock after the bell: where AMZN stands tonight Amazon shares ended Thursday, December…
FedEx Stock Today: FDX Rises After Earnings Beat, Guidance Raise, and Freight Spin-Off Update (Dec. 18, 2025)

FedEx Stock Today: FDX Rises After Earnings Beat, Guidance Raise, and Freight Spin-Off Update (Dec. 18, 2025)

FedEx stock (NYSE: FDX) traded higher in late Thursday trading after the shipping giant delivered a stronger-than-expected fiscal second-quarter report and lifted the low end of its full-year profit outlook. Shares were around $287, up roughly 1%–2% on the session, after swinging between about $282 and nearly $297 as investors digested the results and updated forecast. The market’s immediate focus: a clean earnings beat driven by pricing…
Nike Stock Today (Dec. 18, 2025): NKE Slips After Q2 Earnings Beat as China Weakness and Tariffs Keep Pressure on Margins

Nike Stock Today (Dec. 18, 2025): NKE Slips After Q2 Earnings Beat as China Weakness and Tariffs Keep Pressure on Margins

Nike stock (NYSE: NKE) was volatile on Thursday, December 18, 2025, as investors weighed a headline earnings and revenue beat against a familiar mix of issues: shrinking profit, softer demand in Greater China, and tariff-driven margin pressure. By late U.S. trading, Nike shares were around $65.63, after swinging between roughly $62.20 and $66.96 during the session on heavy volume.  MarketScreener But the bigger move came after the…
FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet Research Systems Inc. (NYSE: FDS) delivered a “beat-and-dip” kind of morning on Thursday, December 18, 2025: the company topped Wall Street expectations for revenue and adjusted earnings in its fiscal first quarter, reaffirmed full‑year guidance, and expanded its share repurchase authorization to $1 billion—yet the stock fell sharply in trading. The Motley Fool That tension captures the current mood…
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Dec. 18, 2025 — Birkenstock Holding plc (NYSE: BIRK) delivered a classic “beat-and-drop” session: strong fiscal 2025 results and record revenue were overshadowed by a more cautious fiscal 2026 outlook that bakes in tariff and currency pressure. SEC As of the latest available trade on Dec. 18, Birkenstock shares were at $42.58, down about 8% on the day, after swinging…
1 191 192 193 194 195 302

Stock Market Today

  • Cantor Fitzgerald Raises Price Target for Regeneron Pharmaceuticals (NASDAQ:REGN)
    February 2, 2026, 11:58 AM EST. Cantor Fitzgerald increased its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) from $740 to $800, maintaining an "overweight" rating, signaling a potential 5% upside. Other brokerages also raised forecasts, with BMO Capital Markets at $850, Guggenheim at $865, and Evercore ISI at $875. Regeneron's shares rose 2.7% to $761.32 amid increased trading volume. The biotech giant posted strong Q4 results with EPS of $11.44 beating estimates, and revenues up 2.5% year-over-year to $3.88 billion. The company holds a solid balance sheet with low debt and robust margins. Market consensus rates the stock as a "Moderate Buy" with an average price target near $790, reflecting optimism about Regeneron's growth prospects.
Go toTop